# BioMotiv, LLC: Form D filings

BioMotiv, LLC, a biotechnology company in Cleveland, OH, filed 7 Form D notices with the SEC between 2012 and 2018. The latest, on August 1, 2018, reports $145.7 million sold of a $200 million offering to 62 investors.

Find out what BioMotiv, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20BioMotiv%2C%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=BioMotiv%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fbiomotiv-llc-1557499)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20BioMotiv%2C%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=BioMotiv%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fbiomotiv-llc-1557499)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Ohio](https://specstream.ai/data/form-d/state/ohio): 1,071 rows, by operating companies, filed since November 1, 2024, $53.55, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/ohio
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 20600 CHAGRIN BLVD., SUITE 210, Cleveland, OH, 44122
- Phone: (216) 455-3216
- Industry: Biotechnology
- Entity type: Limited Liability Company
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1557499

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 1, 2018 | Amendment | $200,000,000 | $145,726,790 | $54,273,210 | 62 | Aug 22, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557499/000155749918000001/0001557499-18-000001-index.htm) |
| Aug 4, 2017 | Amendment | $200,000,000 | $145,726,790 | $54,273,210 | 62 | Aug 22, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557499/000155749917000001/0001557499-17-000001-index.htm) |
| Aug 5, 2016 | Amendment | $200,000,000 | $144,676,790 | $55,323,210 | 62 | Aug 22, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557499/000155749916000002/0001557499-16-000002-index.htm) |
| Aug 6, 2015 | Amendment | $150,000,000 | $81,426,790 | $68,573,210 | 57 | Aug 22, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557499/000155749915000001/0001557499-15-000001-index.htm) |
| Aug 7, 2014 | Amendment | $100,000,000 | $50,976,790 | $49,023,210 | 54 | Aug 22, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557499/000155749914000002/0001557499-14-000002-index.htm) |
| Aug 6, 2013 | Amendment | $100,000,000 | $46,194,555 | $53,805,445 | 47 | Aug 22, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557499/000155749913000001/0001557499-13-000001-index.htm) |
| Sep 5, 2012 | New notice | $100,000,000 | $21,000,000 | $79,000,000 | 2 | Aug 22, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557499/000155749912000002/0001557499-12-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Mark S. Teague | Executive Officer |  |
| Jeffrey S. Edelson, MD | Executive Officer |  |
| Carmen S. Bozic, MD | Director |  |
| Stacie S. Switzer | Executive Officer |  |
| Baiju R. Shah | Executive Officer, Director |  |
| Terry S. Vance | Executive Officer |  |
| Robert S. Reitman | Director |  |
| David C. U'Prichard, Ph.D. | Director |  |
| Charles S. McOsker, Ph.D. | Executive Officer |  |
| Ronald G. Harrington | Director |  |
| Jonathan S. Stamler, M.D. | Director |  |
| Michael S. Martin, Ph.D. | Director |  |
| Theodore S. Torphy, Ph.D. | Executive Officer |  |

## Other biotechnology companies in Ohio that filed recently

- [LAACClamp Inc.](https://specstream.ai/data/form-d/company/laacclamp-inc-2104335) $900,000 · Oct 5, 2026
- [Autology, Inc.](https://specstream.ai/data/form-d/company/autology-inc-2154840) $3.4 million · Sep 30, 2026

[Every Form D from the week of Jul 30, 2018](https://specstream.ai/data/form-d/week/2018-07-30) · [All recent filings in Ohio](https://specstream.ai/data/form-d/state/ohio) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what BioMotiv, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).